The largest purchase of all time was on 2019-07-29 and amounted to 60000 shares of AbbVie Inc. for $4.04M.
The largest sale of all time was on 2022-05-16 and amounted to 83960 shares of AbbVie Inc. for $13.01M.
No biography is available at this moment.
| 2023-09-19 | Neumora Therapeutics, Inc. Common Stock NMRA | President & CEO | 15,000 0.0118% | $12.62 | $189,371 | -1.04% | ||
| 2023-05-09 | Acelyrin, Inc. SLRN | director | 50,000 0.1972% | $18.00 | $900,000 | -63.02% | ||
| 2022-05-16 | Sale | AbbVie Inc. ABBV | EVP, Chief Strategy Officer | 83,960 0.0047% | $155.00 | $13.01M | -1.89% | |
| 2022-03-01 | Sale | AbbVie Inc. ABBV | EVP, Chief Strategy Officer | 25,000 0.0014% | $147.29 | $3.68M | +3.79% | |
| 2020-11-20 | Sale | AbbVie Inc. ABBV | EVP, Chief Strategy Officer | 40,000 0.0024% | $99.38 | $3.98M | +12.51% | |
| 2019-07-29 | AbbVie Inc. ABBV | EVP, Chief Strategy Officer | 60,000 0.0041% | $67.28 | $4.04M | +30.67% | ||
| 2018-11-29 | Sale | AbbVie Inc. ABBV | EVP, Chief Strategy Officer | 84,900 0.0058% | $90.10 | $7.65M | -10.3% | |
| 2017-10-30 | Sale | AbbVie Inc. ABBV | Chief Strategy Officer | 36,600 0.0023% | $90.55 | $3.31M | +7.87% | |
| 2017-07-31 | Sale | AbbVie Inc. ABBV | Chief Strategy Officer | 36,600 0.0023% | $70.11 | $2.57M | +38.38% |